2023 Q3 Form 10-K Financial Statement

#000141057823001476 Filed on July 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q1 2023
Revenue $3.717M $5.928M $22.18M
YoY Change -36.53% 38.16% 13.45%
Cost Of Revenue $2.409M $4.259M $15.83M
YoY Change -43.91% 51.6% 17.1%
Gross Profit $1.308M $1.669M $6.350M
YoY Change -16.23% 12.66% 5.26%
Gross Profit Margin 35.19% 28.15% 28.63%
Selling, General & Admin $1.334M $1.224M $4.974M
YoY Change 12.2% -16.41% -9.95%
% of Gross Profit 102.0% 73.36% 78.34%
Research & Development $130.0K $108.5K $402.7K
YoY Change 25.91% -23.95% -8.1%
% of Gross Profit 9.94% 6.5% 6.34%
Depreciation & Amortization $0.00 -$3.160K $11.69K
YoY Change -100.0% -532.88% 51.94%
% of Gross Profit 0.0% -0.19% 0.18%
Operating Expenses $1.334M $1.333M $5.377M
YoY Change 3.24% -17.08% -9.82%
Operating Profit -$157.6K $336.0K $972.6K
YoY Change -158.56% -366.79% 1295.57%
Interest Expense $33.51K -$36.91K -$237.7K
YoY Change -51.1% -66.41% -260.78%
% of Operating Profit -10.98% -24.44%
Other Income/Expense, Net
YoY Change
Pretax Income -$191.1K $299.1K $734.9K
YoY Change -195.26% -226.83% -1040.36%
Income Tax -$4.672K $14.48K $14.48K
% Of Pretax Income 4.84% 1.97%
Net Earnings -$186.4K $284.6K $720.4K
YoY Change -192.93% -220.69% -1021.83%
Net Earnings / Revenue -5.01% 4.8% 3.25%
Basic Earnings Per Share -$0.08 $0.31
Diluted Earnings Per Share -$0.08 $0.12 $0.31
COMMON SHARES
Basic Shares Outstanding 2.313M 2.313M 2.313M
Diluted Shares Outstanding 2.313M 2.313M

Balance Sheet

Concept 2023 Q3 2023 Q1 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $250.0K $151.5K $151.5K
YoY Change 39.76% -65.47% -65.47%
Cash & Equivalents $254.8K $151.5K
Short-Term Investments
Other Short-Term Assets $370.0K $165.4K $165.4K
YoY Change 12.74% -31.47% -31.47%
Inventory $4.968M $4.064M $4.064M
Prepaid Expenses $365.6K $165.4K
Receivables $822.0K $414.7K $414.7K
Other Receivables $2.310M $3.250M $3.250M
Total Short-Term Assets $8.719M $8.045M $8.045M
YoY Change -21.06% -26.85% -26.85%
LONG-TERM ASSETS
Property, Plant & Equipment $242.5K $318.6K $318.6K
YoY Change -39.09% -33.29% -33.29%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00 $0.00
YoY Change -100.0% -100.0%
Total Long-Term Assets $276.0K $354.4K $354.4K
YoY Change -37.28% -32.09% -32.09%
TOTAL ASSETS
Total Short-Term Assets $8.719M $8.045M $8.045M
Total Long-Term Assets $276.0K $354.4K $354.4K
Total Assets $8.995M $8.400M $8.400M
YoY Change -21.68% -27.09% -27.09%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.990M $948.5K $948.5K
YoY Change 4.96% -39.68% -62.91%
Accrued Expenses $660.0K $461.2K $461.2K
YoY Change 21.89% -38.62% -38.62%
Deferred Revenue
YoY Change
Short-Term Debt $910.0K $1.459M $1.459M
YoY Change -72.9% -54.94% -54.94%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.565M $2.869M $2.869M
YoY Change -45.2% -56.18% -56.18%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $90.00K $172.1K $172.1K
YoY Change -63.71% -48.7% -48.7%
Total Long-Term Liabilities $93.07K $172.1K $172.1K
YoY Change -62.48% -48.7% -48.7%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.565M $2.869M $2.869M
Total Long-Term Liabilities $93.07K $172.1K $172.1K
Total Liabilities $3.658M $3.041M $3.041M
YoY Change -45.83% -55.82% -55.82%
SHAREHOLDERS EQUITY
Retained Earnings -$7.571M -$7.550M
YoY Change -7.4% -8.71%
Common Stock $12.91M $12.91M
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $5.338M $5.359M $5.359M
YoY Change
Total Liabilities & Shareholders Equity $8.995M $8.400M $8.400M
YoY Change -21.68% -27.09% -27.09%

Cashflow Statement

Concept 2023 Q3 2023 Q1 2023
OPERATING ACTIVITIES
Net Income -$186.4K $284.6K $720.4K
YoY Change -192.93% -220.69% -1021.83%
Depreciation, Depletion And Amortization $0.00 -$3.160K $11.69K
YoY Change -100.0% -532.88% 51.94%
Cash From Operating Activities $470.0K $1.145M $1.492M
YoY Change 156.05% 354.49% -180.21%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -460.0K -1.193M -1.779M
YoY Change 76.54% 495.62% -183.21%
NET CHANGE
Cash From Operating Activities 470.0K 1.145M 1.492M
Cash From Investing Activities
Cash From Financing Activities -460.0K -1.193M -1.779M
Net Change In Cash 10.00K -48.66K -287.2K
YoY Change -112.99% -194.47% -203.28%
FREE CASH FLOW
Cash From Operating Activities $470.0K $1.145M $1.492M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.31
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2312887
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2312887
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2312887
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2312887
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0000102109
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 us-gaap Lease Practical Expedients Package
LeasePracticalExpedientsPackage
true
CY2023Q1 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentNet
CY2022Q1 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentNet
CY2023 dei Entity Registrant Name
EntityRegistrantName
UNIVERSAL SECURITY INSTRUMENTS INC
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
001-31747
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
52-0898545
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
11407 Cronhill Drive
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite A
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Owings Mills
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
MD
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
21117
CY2023 dei City Area Code
CityAreaCode
410
CY2023 dei Local Phone Number
LocalPhoneNumber
363-3000
CY2023 dei Security12b Title
Security12bTitle
Common Stock
CY2023 dei Trading Symbol
TradingSymbol
UUU
CY2023 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Public Float
EntityPublicFloat
7970834
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
2312887
CY2023 dei Auditor Firm
AuditorFirmId
688
CY2023 dei Auditor Name
AuditorName
Marcum LLP
CY2023 dei Auditor Location
AuditorLocation
Philadelphia, PA
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
151502
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
438735
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
414689
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
993846
CY2023Q1 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
305889
CY2022Q1 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
303366
CY2023Q1 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
720578
CY2022Q1 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
1297212
CY2023Q1 uuu Due From Factor
DueFromFactor
2944370
CY2022Q1 uuu Due From Factor
DueFromFactor
2792901
CY2023Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
4063632
CY2022Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
6229061
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
165378
CY2022Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
241342
CY2023Q1 us-gaap Assets Current
AssetsCurrent
8045460
CY2022Q1 us-gaap Assets Current
AssetsCurrent
10999251
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
35773
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
40243
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
318641
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
477627
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4000
CY2023Q1 us-gaap Assets
Assets
8399874
CY2022Q1 us-gaap Assets
Assets
11521121
CY2023Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
1459350
CY2022Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
2157086
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
151230
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
131880
CY2023Q1 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
293465
CY2022Q1 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
1572356
CY2022Q1 us-gaap Notes Payable To Bank Current
NotesPayableToBankCurrent
1081440
CY2023Q1 uuu Accounts Payable To Related Parties Current
AccountsPayableToRelatedPartiesCurrent
655000
CY2022Q1 uuu Accounts Payable To Related Parties Current
AccountsPayableToRelatedPartiesCurrent
985077
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
125415
CY2022Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
160025
CY2023Q1 uuu Accrued Commissions And Other
AccruedCommissionsAndOther
184525
CY2022Q1 uuu Accrued Commissions And Other
AccruedCommissionsAndOther
459440
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
2868985
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
6547304
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
172072
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
335411
CY2023Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
172072
CY2022Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
335411
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2312887
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2312887
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
23129
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
23129
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
12885841
CY2022Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
12885841
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7550153
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-8270564
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
5358817
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
4638406
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8399874
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11521121
CY2023 us-gaap Revenues
Revenues
22178873
CY2022 us-gaap Revenues
Revenues
19549785
CY2023 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
15829154
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
13517552
CY2023 us-gaap Gross Profit
GrossProfit
6349719
CY2022 us-gaap Gross Profit
GrossProfit
6032233
CY2023 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4974453
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5524343
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
402692
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
438200
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
972574
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
69690
CY2023 us-gaap Interest Expense
InterestExpense
237686
CY2022 us-gaap Interest Expense
InterestExpense
147840
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
734888
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-78150
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14477
CY2023 us-gaap Net Income Loss
NetIncomeLoss
720411
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-78150
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.31
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2312887
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2312887
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
4716556
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-78150
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
4638406
CY2023 us-gaap Net Income Loss
NetIncomeLoss
720411
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
5358817
CY2023 us-gaap Profit Loss
ProfitLoss
720411
CY2022 us-gaap Profit Loss
ProfitLoss
-78150
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
11692
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7694
CY2023 uuu Depreciation Of Right Of Use Asset And Decrease In Other Assets
DepreciationOfRightOfUseAssetAndDecreaseInOtherAssets
155764
CY2022 uuu Depreciation Of Right Of Use Asset And Decrease In Other Assets
DepreciationOfRightOfUseAssetAndDecreaseInOtherAssets
171122
CY2022 uuu Increase Decrease In Allowance For Inventory Reserve
IncreaseDecreaseInAllowanceForInventoryReserve
70000
CY2023 uuu Increase Decrease In Accounts Receivable And Due From Factor
IncreaseDecreaseInAccountsReceivableAndDueFromFactor
-425165
CY2022 uuu Increase Decrease In Accounts Receivable And Due From Factor
IncreaseDecreaseInAccountsReceivableAndDueFromFactor
1506650
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2165429
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1977868
CY2023 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-75964
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-95357
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1918493
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1669566
CY2023 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-143989
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-171122
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1491943
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1860051
CY2023 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1081440
CY2023 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-697736
CY2022 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
2138182
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1779176
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2138182
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-287233
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
278131
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
438735
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
160604
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
151502
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
438735
CY2023 us-gaap Interest Paid Net
InterestPaidNet
237686
CY2022 us-gaap Interest Paid Net
InterestPaidNet
147840
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
467291
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Use of Estimates:</span> In preparing financial statements in conformity with accounting principles generally accepted in the United States of America (US-GAAP), management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. On an ongoing basis, we evaluate these estimates, including those related to bad debts, inventories, income taxes, and contingencies and litigation. We base these estimates on historical experiences and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily available from other sources. Actual results could differ from those estimates.</p>
CY2023 us-gaap Revenues
Revenues
22178873
CY2022 us-gaap Revenues
Revenues
19549785
CY2023 uuu Factoring Charges
FactoringCharges
191225
CY2022 uuu Factoring Charges
FactoringCharges
165579
CY2023Q1 uuu Allowance For Uncollectible Financing Receivables
AllowanceForUncollectibleFinancingReceivables
0
CY2023Q1 uuu Financing Receivables Past Due
FinancingReceivablesPastDue
0
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
157000
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
157000
CY2023 uuu Inventory Quality Control Expenses
InventoryQualityControlExpenses
45000
CY2022 uuu Inventory Quality Control Expenses
InventoryQualityControlExpenses
45000
CY2022 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2023 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2023 us-gaap Guarantees Indemnifications And Warranties Policies
GuaranteesIndemnificationsAndWarrantiesPolicies
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Warranties:</span> We generally provide warranties, on the safety products, from <span style="-sec-ix-hidden:Hidden_YYh_Dst_nkWRfS2sGWr-ZQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">one</span></span> to ten years to the non-commercial end user on all products sold. The manufacturers of our safety products provide us with a one-year warranty on all products we purchase for resale. Claims for warranty replacement of products beyond the one-year warranty period covered by the manufacturers have not been historically material.</p>
CY2023 uuu Warranty Period For Products Purchased For Resale
WarrantyPeriodForProductsPurchasedForResale
P1Y
CY2023 uuu Warranty Period For Products Purchased For Resale
WarrantyPeriodForProductsPurchasedForResale
P1Y
CY2023 uuu Shipping And Handling Costs
ShippingAndHandlingCosts
524016
CY2022 uuu Shipping And Handling Costs
ShippingAndHandlingCosts
426740
CY2022 uuu Securities Outstanding Other Than Common Stock
SecuritiesOutstandingOtherThanCommonStock
0
CY2023 uuu Securities Outstanding Other Than Common Stock
SecuritiesOutstandingOtherThanCommonStock
0
CY2023 us-gaap Line Of Credit Facility Borrowing Capacity Description
LineOfCreditFacilityBorrowingCapacityDescription
Under the modified Agreement the Company may borrow eighty percent (80%) of eligible accounts receivable. Additional funding, characterized by Merchant as an over advance, may be provided up to one hundred percent (100%) of eligible accounts receivable. The over advance portion, if any, may not exceed fifty percent (50%) of eligible inventory up to a maximum of $500,000.
CY2023 uuu Factoring Agreement Receivables Sold
FactoringAgreementReceivablesSold
22581988
CY2022 uuu Factoring Agreement Receivables Sold
FactoringAgreementReceivablesSold
18449900
CY2023Q1 uuu Due From Factor
DueFromFactor
2944370
CY2022Q1 uuu Due From Factor
DueFromFactor
2792901
CY2023Q1 us-gaap Accounts Receivable Unapproved Contract Claims Amount Expected To Be Collected Within One Year
AccountsReceivableUnapprovedContractClaimsAmountExpectedToBeCollectedWithinOneYear
633000
CY2022Q1 us-gaap Accounts Receivable Unapproved Contract Claims Amount Expected To Be Collected Within One Year
AccountsReceivableUnapprovedContractClaimsAmountExpectedToBeCollectedWithinOneYear
589000
CY2023 us-gaap Line Of Credit Facility Interest Rate Description
LineOfCreditFacilityInterestRateDescription
Collected cash maintained on deposit with the factor earns interest at the factor’s prime rate of interest less 2.5 percent (effective rate of 5.50% and 1.00% at March 31, 2023 and 2022, respectively.)
CY2023 uuu Estimated Useful Lives
EstimatedUsefulLives
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:top;width:45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr><td style="vertical-align:top;width:45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-align:justify;text-indent:-7.2pt;margin:0pt;">Leasehold improvements</p></td><td style="vertical-align:top;width:5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">-</p></td><td style="vertical-align:top;width:50%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Shorter of term of lease or useful life of asset</p></td></tr><tr><td style="vertical-align:top;width:45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-align:justify;text-indent:-7.2pt;margin:0pt;">Machinery and equipment</p></td><td style="vertical-align:top;width:5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">-</p></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">5 to <span style="-sec-ix-hidden:Hidden_gOz7e1FxtUaQ6necHIXgSg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">10 years</span></span></p></td></tr><tr><td style="vertical-align:top;width:45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-align:justify;text-indent:-7.2pt;margin:0pt;">Furniture and fixtures</p></td><td style="vertical-align:top;width:5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">-</p></td><td style="vertical-align:top;width:50%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">5 to <span style="-sec-ix-hidden:Hidden_xHCmlE_5FEKm1g6WpEksBQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">15 years</span></span></p></td></tr><tr><td style="vertical-align:top;width:45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-align:justify;text-indent:-7.2pt;margin:0pt;">Computer equipment</p></td><td style="vertical-align:top;width:5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">-</p></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">5 years</p></td></tr></table>
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1874287
CY2022Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1874287
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1555646
CY2022Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1396660
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
318641
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
477627
CY2023 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
158986
CY2023 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
155764
CY2022 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
174342
CY2022 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
171122
CY2023 us-gaap Operating Lease Expense
OperatingLeaseExpense
15000
CY2023 uuu Operating Lease Rent Increment Percentage
OperatingLeaseRentIncrementPercentage
0.030
CY2023 uuu Monthly Rental Expenses
MonthlyRentalExpenses
4900
CY2023 uuu Operating Lease Rent Expenses
OperatingLeaseRentExpenses
265990
CY2022 uuu Operating Lease Rent Expenses
OperatingLeaseRentExpenses
252975
CY2023 uuu Non Cash Right Of Use Asset In Exchange For Operating Lease Liability
NonCashRightOfUseAssetInExchangeForOperatingLeaseLiability
485000
CY2023 uuu Adoption Of Lease Expenses Increased
AdoptionOfLeaseExpensesIncreased
468000
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
311527
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
323302
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.055
CY2023 us-gaap Operating Lease Payments
OperatingLeasePayments
143989
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
184370
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
467291
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
467291
CY2022Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y
CY2022Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.055
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
175770
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
175770
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
116918
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
159398
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
53492
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
329808
CY2023Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
6506
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
323302
CY2023Q1 uuu Operating Lease Liabilities Current
OperatingLeaseLiabilitiesCurrent
151230
CY2023Q1 uuu Operating Lease Liabilities Noncurrent
OperatingLeaseLiabilitiesNoncurrent
172072
CY2023Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
5253000
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
154326
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-16412
CY2023 uuu Income Tax Reconciliation Permanent Differences
IncomeTaxReconciliationPermanentDifferences
-24657
CY2022 uuu Income Tax Reconciliation Permanent Differences
IncomeTaxReconciliationPermanentDifferences
12017
CY2023 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
24558
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
15646
CY2023 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
139750
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
11251
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14477
CY2023Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Returns And Allowances
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances
68553
CY2022Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Returns And Allowances
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances
68553
CY2023Q1 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
6196
CY2022Q1 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
54895
CY2023Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
1103173
CY2022Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
1194224
CY2022Q1 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
61701
CY2023Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1239623
CY2022Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1379373
CY2023Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
75947
CY2022Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
358958
CY2023 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.04
CY2023 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
45777
CY2022 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
43688
CY2023 uuu Capitalization Finite Lived Intangible Assets Legal Expenses
CapitalizationFiniteLivedIntangibleAssetsLegalExpenses
89434
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4470
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4474
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
53661
CY2022Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
49191
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
4472
CY2022Q1 us-gaap Long Term Debt
LongTermDebt
100000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
120000

Files In Submission

Name View Source Status
R34.htm Edgar Link pending
0001410578-23-001476-index-headers.html Edgar Link pending
0001410578-23-001476-index.html Edgar Link pending
0001410578-23-001476.txt Edgar Link pending
0001410578-23-001476-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
uuu-20230331.xsd Edgar Link pending
uuu-20230331x10k.htm Edgar Link pending
uuu-20230331xex23d1.htm Edgar Link pending
uuu-20230331xex31d1.htm Edgar Link pending
uuu-20230331xex31d2.htm Edgar Link pending
uuu-20230331xex32d1.htm Edgar Link pending
uuu-20230331xex99d1.htm Edgar Link pending
uuu-20230331xex99d1001.jpg Edgar Link pending
uuu-20230331_def.xml Edgar Link unprocessable
uuu-20230331_lab.xml Edgar Link unprocessable
uuu-20230331x10k_htm.xml Edgar Link completed
uuu-20230331_cal.xml Edgar Link unprocessable
uuu-20230331_pre.xml Edgar Link unprocessable